Why Personalized Medicine Poses HTA & Funding Challenges In England

Personalized medicine models could benefit patients, but this approach raises tough economic and prioritization questions for health technology assessment bodies like England’s NICE.

Japan's HTA Scheme Entered Fourth Year With 14 Drugs Under Its Evaluation.
• Source: Shutterstock

More from AI

More from Advanced Technologies